Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

See all formats and pricing


Select Volume and Issue


30,00 € / $42.00 / £23.00

Get Access to Full Text

Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis

Edward Bańkowski / Krzysztof Sobolewski / Jerzy Palka / Stefan Jaworski
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.032


Insulin-like growth factor-I (IGF-I) is known as an important stimulator of collagen and glycosaminoglycans (GAGs) biosynthesis in tissues. IGF-I activity is under control of IGF-I-binding proteins (IGFBPs) with different IGF-I-binding affinity. IGFBP-1 is known as an inhibitor of IGF-dependent functions. Some IGFBPs (e.g., IGFBP-1) may undergo phosphorylation that dramatically increases IGFBP affinity for IGF. Wharton's jelly represents a reservoir of IGF-I and its binding proteins (BPs). Pre-eclampsia, the most common, pregnancy-associated pathological syndrome, contributes to a significant decrease in IGF-I and IGFBP-1 content in Wharton's jelly, although it does not affect collagen content in this tissue. In the present study we show that control Wharton's jelly contains phosphorylated forms of IGFBP-1 that are dramatically dephosphorylated during pre-eclampsia. A dramatic decrease in IGF-I binding to immunoprecipitated IGFBP-1 from pre-eclamptic Wharton's jelly compared to the control was observed. Western immunoblot analysis with anti-phosphothreonine antibodies for immunoprecipitated IGFBP-1 from control and pre-eclamptic Wharton's jelly revealed that both tissues contain phosphorylated forms of IGFBP-1. However, a distinct decrease in the expression of phosphorylated IGFBP-1 from pre-eclamptic Wharton's jelly was observed. The functional significance of the phenomenon was found in cultured fibroblasts treated with IGFBP isolated from Wharton's jelly extracts. A significant decrease in collagen biosynthesis was found in the cells treated with IGFBP of control Wharton's jelly, while in the presence of IGFBP from pre-eclamptic Wharton's jelly, the rate of collagen biosynthesis was similar to that in the control cells. The result was corroborated by data showing increase in expression of IGF-I receptor and phosphorylated MAP kinases (ERK1 and ERK2) in fibroblasts cultured in the presence of IGFBP from pre-eclamptic Wharton's jelly, compared to control. The data suggest that the decrease in phosphorylated IGFBP-1 in pre-eclamptic Wharton's jelly may decrease IGF-I-binding affinity for IGF and increase the bioavailability of IGF-I for receptor interaction. This mechanism may facilitate IGF-I-dependent stimulation of fibroblasts to produce extracellular matrix (ECM) components even at a low IGF-I tissue level. Therefore, IGFBP-1 phosphoisoforms in Wharton's jelly may play an important role in the regulation of IGF-I-dependent functions during pre-eclampsia.

Published Online: 2005-06-01

Published in Print: 2004-02-18

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 42, Issue 2, Pages 175–181, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.032, June 2005

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Lorenzo Dolcini, Alberto Sala, Monica Campagnoli, Sara Labò, Maurizia Valli, Livia Visai, Lorenzo Minchiotti, Hugo L. Monaco, and Monica Galliano
FEBS Journal, 2009, Volume 276, Number 20, Page 6033
Javad Khosravi, Radha G. Krishna, Umesh Bodani, Anastasia Diamandi, Najmuddin Khaja, Bhanu Kalra, and Ajay Kumar
Clinical Biochemistry, 2007, Volume 40, Number 1-2, Page 86
K. Sobolewski, A. Małkowski, E. Bańkowski, and S. Jaworski
Placenta, 2005, Volume 26, Number 10, Page 747
Christina Vock, Mareike Gleissner, Maja Klapper, and Frank Döring
Biochimica et Biophysica Acta (BBA) - General Subjects, 2007, Volume 1770, Number 9, Page 1283
Alp Can and Sercin Karahuseyinoglu
Stem Cells, 2007, Volume 25, Number 11, Page 2886
S. M. Skulstad, M. Ulriksen, S. Rasmussen, and T. Kiserud
Ultrasound in Obstetrics and Gynecology, 2006, Volume 28, Number 5, Page 692

Comments (0)

Please log in or register to comment.